{"database":"biostudies-literature","file_versions":[],"scores":null,"additional":{"submitter":["Harrold EC"],"funding":["NCI NIH HHS"],"pagination":["1623-1630"],"full_dataset_link":["https://www.ebi.ac.uk/biostudies/studies/S-EPMC9337980"],"repository":["biostudies-literature"],"omics_type":["Unknown"],"volume":["18(12)"],"pubmed_abstract":["Background
The NCCN Guidelines for Survivorship recommend dedicated sleep assessment. Reported insomnia prevalence in the general Irish population is 6% to 15%. Reported insomnia prevalence internationally among new/recently diagnosed patients with cancer varies from 30.9% to 54.3%. Insomnia prevalence has not been previously quantified in an Irish oncology cohort.Methods
A 40-item questionnaire was prospectively administered to ambulatory patients with cancer aged ≥18 years. Prespecified criteria to define insomnia syndrome combined those of the International Classification of Sleep Disorders, version 1, and the Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition (DSM-IV). The Hospital Anxiety and Depression Scale-Depression/Anxiety (HADS-D/A) was used to"],"journal":["Journal of the National Comprehensive Cancer Network : JNCCN"],"pubmed_title":["Prevalence of Insomnia in an Oncology Patient Population: An Irish Tertiary Referral Center Experience."],"pmcid":["PMC9337980"],"funding_grant_id":["P30 CA008748"],"pubmed_authors":["O'Donnell DM","Kingston T","Idris AF","Grant C","Collier S","Keegan NM","Cuffe S","Corrigan L","Teo MY","O'Donnell M","Gallagher DG","Kennedy MJ","Lim ST","Sukor S","O'Dwyer AM","Harrold EC","Duff E"],"additional_accession":[]},"is_claimable":false,"name":"Prevalence of Insomnia in an Oncology Patient Population: An Irish Tertiary Referral Center Experience.","description":"Background
The NCCN Guidelines for Survivorship recommend dedicated sleep assessment. Reported insomnia prevalence in the general Irish population is 6% to 15%. Reported insomnia prevalence internationally among new/recently diagnosed patients with cancer varies from 30.9% to 54.3%. Insomnia prevalence has not been previously quantified in an Irish oncology cohort.Methods
A 40-item questionnaire was prospectively administered to ambulatory patients with cancer aged ≥18 years. Prespecified criteria to define insomnia syndrome combined those of the International Classification of Sleep Disorders, version 1, and the Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition (DSM-IV). The Hospital Anxiety and Depression Scale-Depression/Anxiety (HADS-D/A) was used to","dates":{"release":"2020-01-01T00:00:00Z","publication":"2020 Dec","modification":"2025-04-04T19:27:25.601Z","creation":"2025-04-04T19:27:25.601Z"},"accession":"S-EPMC9337980","cross_references":{"pubmed":["33285516"],"doi":["10.6004/jnccn.2020.7611"]}}